Zur Pharmakokinetik von Lipidsenkern, 9.Mitt.: Zur Frage der biliären Ausscheidung des Lipidsenkers Ciprofibrat (1) (2-[4-(2,2-Dichlorcyclopropyl)-phenoxy]-2-methylpropionsäure)-Reference-Cited by-同舟云学术

Zur Pharmakokinetik von Lipidsenkern, 9.Mitt.: Zur Frage der biliären Ausscheidung des Lipidsenkers Ciprofibrat (1) (2-[4-(2,2-Dichlorcyclopropyl)-phenoxy]-2-methylpropionsäure)

Published:1992 Issue:11 Volume:325 Page:701-704
ISSN:0365-6233
Container-title:Archiv der Pharmazie
language:de
Short-container-title:Arch. Pharm. Pharm. Med. Chem.

Author:

Oelschläger Herbert,Rothley Dietrich,Schröder Dieter,Scherm Sabine

Publisher

Wiley

Subject

Drug Discovery,Pharmaceutical Science

Reference9 articles.

1. Comparative evaluation of the effects of ciprofibrate and fenofibrate on lipids, lipoproteins and apoproteins A and B

2. Efficacy, long term tolerance and persistance of the effects of Ciprofibrate, JAMA-France (Suppl.): 4–5. Februar 1987.

3. und , Hyperlipidemie et Ciprofibrate: L'expérience des generalistes, Le quotidien du Medicin; (Suppl.): 1–22. September 1986.

4. Zur Pharmakokinetik Von Lipidsenkern, 8. Mitt.: Eindeutige Charakterisierung Des Ciprofibrat-o-β-D-Giukuronids

5. und , Arzneim.-Forsch. (im Druck).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Achiral and chiral determination of ciprofibrate and its glucuronide in human urine by capillary electrophoresis;Journal of Chromatography B: Biomedical Sciences and Applications;1999-06

2. Chromatographic resolution of Ciprofibrate and interaction of the racemate and both enantiomers with rat liver microsomes in vitro;Experimental and Toxicologic Pathology;1998-09

3. Ciprofibrate — racemate and enantiomers: Effects of a four-week treatment on male inbred Fischer rats. A biochemical and morphological study;Experimental and Toxicologic Pathology;1998-09

4. Zur Pharmakokinetik von Lipidsenkern, 10. Mitt.: Zweiter Beitrag zur Frage der Dehalogenierung des Lipidsenkers Ciprofibrat;Archiv der Pharmazie;1994